Malibu Life Holdings (LSE:MLHL) Research & Development: $0.0 Mil (TTM As of Dec. 2025)


LSE:MLHL Malibu Life Holdings Ltd LSE:MLHL
33 GF Score
Price $16.00
! 3 Warning Signs
View Full Analysis

What is Malibu Life Holdings Research & Development?

Malibu Life Holdings LSE:MLHL -1.84% 33 Research & Development is $0.0 Mil as of Dec. 2025. GuruFocus rates LSE:MLHL with a GF Score™ of 33/100. The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Malibu Life Holdings's Research & Development for the six months ended in Dec. 2025 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0.0 Mil.

Malibu Life Holdings  (LSE:MLHL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Malibu Life Holdings Research & Development Related Terms

Malibu Life Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Malibu Life Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Malibu Life Holdings Research & Development Chart

Malibu Life Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Malibu Life Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
LSE:MLHL
33GF Score
Malibu Life Holdings Ltd LSE:MLHL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Malibu Life Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
Malibu Life Holdings (LSE:MLHL) has a Research & Development of $0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Malibu Life Holdings and its competitors.
Is Malibu Life Holdings' Research & Development too high?
Malibu Life Holdings' current Research & Development is $0.0 Mil. Overall, Malibu Life Holdings has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Malibu Life Holdings' Research & Development compare to RGA and EG?
Malibu Life Holdings' Research & Development of $0.0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Malibu Life Holdings and its competitors. Malibu Life Holdings's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Malibu Life Holdings stock overvalued right now?
Malibu Life Holdings (LSE:MLHL) has a current Research & Development of $0.0 Mil. The current Research & Development is $0.0 Mil. Malibu Life Holdings' overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Malibu Life Holdings (LSE:MLHL), the current Research & Development is $0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Malibu Life Holdings Business Description

Address 190 Elgin Avenue, George Town, Grand Cayman, CYM, KY1-9001
Malibu Life Holdings Ltd operates as a annuity reinsurance company. The company has partnered with insurers by providing asset-intensive reinsurance solutions supported by integrated asset management capabilities.
33GF Score

Get the complete analysis for LSE:MLHL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.00
Price